← Back to Clinical Trials
RecruitingNCT04701723

Interest of Cardiac Coherence in the Prevention of Chronic Post-traumatic Stress Disorder: Pilot Study

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionPost-traumatic Stress Disorder
SponsorCentre Hospitalier Universitaire de la Réunion
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment44
SexALL
Min Age18 Years
Max AgeN/A
Start Date2021-07-19
Completion2027-05
Interventions
cardiac coherence

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

ThThe aim of this study is to determinate the potential benefits of a respiratory training program (cardiac coherence, CC) in patients suffering from acute stress disorder, after a potentially traumatic event. Using this method is supposed to prevent the onset of chronic post traumatic stress disorder after 3 months. This pilot study will help to determinate the need of developing this kind of complementary and alternative program, and will also provide knowledge about the feasibiility and acceptability of this program for the patients.

Eligibility Criteria

Inclusion Criteria: * patients seen at medico-psychological emergency cell * patients with an acute stress disorder, diagnosed by DSM-5 * patients who have experienced a potentially traumatic event for the last 3-15 days (vctim or witness) * patients able to read and write in French language * person affiliated or beneficiary of a social security scheme. * person who agrees to participate in the study Exclusion Criteria: * patients with respiratory pathology not allowing cardiac coherence training * patients currently practicing a regular respiratory control technique or within the last 6 months * patients taking beta-blocker, betamimetic, anti-arrhythmic, opioid, antidepressant * patients with a pacemaker or suffering from severe cardiac illness * patients with non-stabilized psychiatric disorder at inclusion * patient taking benzodiazepine unable to wean off in the week following the inclusion * patients with addiction * patients with a cognitive deficit * patients under guardianship

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology